Farnesoid X receptor expression is reduced in human hepatocellular carcinoma

Zhang Wenyu1; Chen Ping2; Zhao Yuanyin3; Lou Guiyu3 1Department of Endocrinology; People’s Hospital of Zhengzhou; Zhengzhou 450003; China 2Department of Hepatobiliary Surgery; Daping Hospital; Institute of Surgery Research; Third Military Medical University; Chongqing 400042; China 3Department of Biochemistry; College of Basic Medical Sciences; Third Military Medical University; Chongqing 400038; China

您当前的位置：

首页 >

文章列表页 >

Farnesoid X receptor expression is reduced in human hepatocellular carcinoma

更新时间：2026-03-12

- Farnesoid X receptor expression is reduced in human hepatocellular carcinoma
- Farnesoid X receptor expression is reduced in human hepatocellular carcinoma
- Zhang Wenyu1 ，Chen Ping2 ，Zhao Yuanyin3 ，Lou Guiyu3 1Department of Endocrinology ，People’s Hospital of Zhengzhou ，Zhengzhou 450003 ，China 2Department of Hepatobiliary Surgery ，Daping Hospital ，Institute of Surgery Research ，Third Military Medical University ，Chongqing 400042 ，China 3Department of Biochemistry ，College of Basic Medical Sciences ，Third Military Medical University ，Chongqing 400038 ，China
- 解放军医学杂志（英文版） 2012年27卷第1期页码：1-9
- 作者机构：
- 作者简介：
- 基金信息：
  Supported by the National Natural Science Foundation of China（30600299）
- DOI：
  中图分类号：
- 稿件说明：
移动端阅览
DOI：
DOI：

HTML全文
出版信息
数据统计

摘要

Abstract

关键词

Keywords

references

5

浏览量

32

下载量

0

CSCD

文章被引用时，请邮件提醒。

提交

工具集

BibTeX下载
Endnote下载
RefMan 下载
NoteExpress下载
NoteFirst下载

关联资源

Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies

From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity